Selective apoptosis of pluripotent mouse and human stem cells by novel ceramide analogues prevents teratoma formation and enriches for neural precursors in ES cell-derived neural transplants.
Selective apoptosis of pluripotent mouse and human stem cells by novel ceramide analogues prevents teratoma formation and enriches for neural precursors in ES cell-derived neural transplants.
复制标题
DOI：
10.1083/jcb.200405144
复制
发表时间：
2004-11-22
期刊：
影响因子：
--
通讯作者：
Condie BG
中科院分区：
文献类型：
--
作者：
Bieberich E;Silva J;Wang G;Krishnamurthy K;Condie BG
The formation of stem cell–derived tumors (teratomas) is observed when engrafting undifferentiated embryonic stem (ES) cells, embryoid body–derived cells (EBCs), or mammalian embryos and is a significant obstacle to stem cell therapy. We show that in tumors formed after engraftment of EBCs into mouse brain, expression of the pluripotency marker Oct-4 colocalized with that of prostate apoptosis response-4 (PAR-4), a protein mediating ceramide-induced apoptosis during neural differentiation of ES cells. We tested the ability of the novel ceramide analogue N-oleoyl serinol (S18) to eliminate mouse and human Oct-4(+)/PAR-4(+) cells and to increase the proportion of nestin(+) neuroprogenitors in EBC-derived cell cultures and grafts. S18-treated EBCs persisted in the hippocampal area and showed neuronal lineage differentiation as indicated by the expression of β-tubulin III. However, untreated cells formed numerous teratomas that contained derivatives of endoderm, mesoderm, and ectoderm. Our results show for the first time that ceramide-induced apoptosis eliminates residual, pluripotent EBCs, prevents teratoma formation, and enriches the EBCs for cells that undergo neural differentiation after transplantation.
登录
查看更多内容
影响因子：
4.8
作者：
Bieberich, E;Kawaguchi, T;Yu, RK
通讯作者：
Yu, RK
影响因子：
82.9
作者：
Guo, Q;Fu, WM;Mattson, MP
通讯作者：
Mattson, MP
影响因子：
4
作者：
Gurumurthy, S;Rangnekar, VM
通讯作者：
Rangnekar, VM
影响因子：
4.8
作者：
Laudanna, C;Mochly-Rosen, D;Butcher, EC
通讯作者：
Butcher, EC
影响因子：
2.7
作者：
Cai, JL;Wu, YY;Rao, MS
通讯作者：
Rao, MS